EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of pathology & …, 2021 - meridian.allenpress.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

Positive predictive value of prostate imaging reporting and data system version 2 for the detection of clinically significant prostate cancer: a systematic review and meta …

E Mazzone, A Stabile, F Pellegrino, G Basile… - European urology …, 2021 - Elsevier
Context The variability of the positive predictive value (PPV) represents a significant factor
affecting the diagnostic performance of multiparametric magnetic resonance imaging …

[HTML][HTML] Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation

B Israël, M van der Leest, M Sedelaar, AR Padhani… - European urology, 2020 - Elsevier
Background There is large variability among radiologists in their detection of clinically
significant (cs) prostate cancer (PCa) on multiparametric magnetic resonance imaging …

French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease

G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022 - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

The current role of MRI for guiding active surveillance in prostate cancer

G Ploussard, O Rouvière, M Rouprêt… - Nature Reviews …, 2022 - nature.com
Active surveillance (AS) is the recommended treatment option for low-risk and favourable
intermediate-risk prostate cancer management, preserving oncological and functional …

[HTML][HTML] Diagnostic performance of a magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: a systematic review …

MJ Hagens, MF Salamanca, AR Padhani… - European Urology Open …, 2022 - Elsevier
Context Systematic biopsies are additionally recommended to maximize the diagnostic
performance of the magnetic resonance imaging (MRI) diagnostic pathway for men with …

Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway

T Barrett, M de Rooij, F Giganti, C Allen… - Nature Reviews …, 2023 - nature.com
Multiparametric MRI of the prostate is now recommended as the initial diagnostic test for
men presenting with suspected prostate cancer, with a negative MRI enabling safe …

Using Prostate Imaging-Reporting and Data System (PI-RADS) scores to select an optimal prostate biopsy method: a secondary analysis of the Trio study

M Ahdoot, AH Lebastchi, L Long, AR Wilbur… - European urology …, 2022 - Elsevier
Background While magnetic resonance imaging (MRI)-targeted biopsy (TBx) results in better
prostate cancer (PCa) detection relative to systematic biopsy (SBx), the combination of both …

Transperineal versus transrectal magnetic resonance imaging–targeted biopsies for prostate cancer diagnosis: final results of the randomized PERFECT trial (CCAFU …

G Ploussard, E Barret, G Fiard, L Lenfant… - European Urology …, 2024 - Elsevier
Background Recent guidelines favor transperineal (TP) prostate biopsies over the
transrectal (TR) approach due to a reduced sepsis risk. Yet, evidence from controlled trial …